FDA Inspection 826402 — Kenneth L Todd III, MD
The FDA completed an inspection of Kenneth L Todd III, MD on Apr 5, 2013 in Dothan, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 5, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dothan, AL (United States)
Additional Details
Clinical Investigator (CI)